Cupid announces strategic investment in fragrance brand Mansam

Cupid Ltd, an Indian healthcare products manufacturer, has signed a term sheet to acquire a strategic stake in Mansam, a Saudi Arabian luxury fragrance brand. The investment, facilitated through a fund managed by GII Investment Management Limited, aims to expand Cupid's international presence and tap into new consumer-driven markets.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FE9vkby
via IFTTT

Read More

Biocon inaugurates first manufacturing facility in US

Biocon Ltd has inaugurated its first US manufacturing facility in Cranbury, New Jersey, operated by its subsidiary, Biocon Generics Inc. Following the acquisition of the Oral Solid Dosage facility from Eywa Pharma Inc in 2023, Biocon invested over USD 30 million to establish the plant.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/r8AKiHu
via IFTTT

Read More

Dr Reddy's inks pact with Johnson & Johnson to acquire vertigo treatment brand

Dr. Reddy's Laboratories has finalized its acquisition of the Stugeron brand from Johnson & Johnson, encompassing EMEA regions, India, and Vietnam. This strategic move allows Dr. Reddy's to broaden its presence in the anti-vertigo market and reinforce its Central Nervous System portfolio. The company aims to extend Stugeron's reach across 18 key markets, aligning with its goal of reaching 1.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ipQhes9
via IFTTT

Read More

Delhi HC stops drug body from taking action against IndiaMart

The Delhi High Court has temporarily blocked the CDSCO from pursuing criminal action against IndiaMart for allegedly listing unapproved medicines. This decision follows complaints regarding the online marketplace listing drugs like Crysvita, Oxbryta, and Jynneos, which are not approved for sale in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nzouJ3S
via IFTTT

Read More

Indian hospitals to raise IT innovation spend by 25% in 3 years: Report

Indian hospitals are poised to significantly increase their IT innovation spending, with a large portion of healthcare providers already dedicating a substantial part of their IT budgets to digital advancements. The focus will be on enhancing patient experience, improving clinical outcomes through technology, and enabling data-driven decision-making.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2npRztj
via IFTTT

Read More

WHO adds popular weight-loss drugs to essential medicines list

The World Health Organization has included Semaglutide and Tirzepatide, popular weight-loss drugs, in its Model List of Essential Medicines. This decision could significantly lower the prices of these medications in countries like India, where obesity rates have surged. The WHO aims to improve access and health outcomes by prioritizing those in need and encouraging generic competition.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/B7hnD36
via IFTTT

Read More

Medicines may soon come with braille labels, audio QR codes

India's drug regulatory authority is exploring the addition of braille cards and voice-assisted QR codes on medicine strips to improve accessibility for visually impaired individuals. This initiative follows representations highlighting the difficulties faced by blind individuals in identifying medicines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/u7VMezX
via IFTTT

Read More